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a b s t r a c t
Human rhinovirus (HRV) is a major causative agent of the common cold, and thus has several important
health implications. As a member of the picornavirus family, HRV has a small genomic RNA that utilizes
several host cell proteins for RNA replication. Host proteins poly(rC) binding protein 2 (PCBP2) and
polypyrimidine tract binding protein (PTB) are cleaved by a viral proteinase during the course of infection
by the related picornavirus, poliovirus. The cleavage of PCBP2 and PTB inhibits poliovirus translation and
has been proposed to mediate a switch in poliovirus template usage from translation to RNA replication.
HRV RNA replication also requires a switch in template usage from translation to RNA replication;
however, the mechanism is not yet known. We demonstrate that PCBP2 and PTB are differentially
cleaved during HRV infection in different cell lines, suggesting that HRV utilizes a mechanism distinct
from PCBP2 or PTB cleavage to mediate a switch in template usage.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Human rhinovirus (HRV) is the most prevalent causative agent of
the common cold, with 80% of common cold cases caused by HRV
(Arruda et al., 1997). Although the common cold is not known to cause
a severe disease phenotype, it costs billions of dollars per year and
contributes to lost wages (McErlean et al., 2008). Additionally, HRV
infections can be severe in individuals with chronic lung illnesses such
as COPD, asthma, or allergies. HRV is a major cause of asthma
exacerbations, causing up to 70% of asthma exacerbations in children
and can increase the rate of morbidity from decreased lung function
due to asthma (Johnston et al., 1996; Rakes et al., 1999). Therefore,
a better understanding of HRV will allow for antiviral drugs to be
developed to help those with chronic lung illnesses. A potential
impediment to development of an antiviral drug is that there are
over 100 antigenically distinct serotypes of HRV. These serotypes can
be divided into three groups, group A, group B, or group C. Addition-
ally, serotypes are grouped based on the receptor used for host cell
entry. Most HRV types use ICAM-I as a receptor and are known as the
major group serotypes, while the remaining minor group types utilize
a low-density lipoprotein (LDL) receptor.
HRV is a member of the Picornaviridae family of viruses, which also
includes coxsackievirus, enterovirus 71, and poliovirus, the prototypic
picornavirus, among others. Picornaviruses are a family of small,
single-stranded, positive-sense RNA viruses that replicate in the
cytoplasm of infected host cells. Unlike cellular mRNAs, picornavirus
genomes lack a cap on the 5′ end and have a highly structured 5′
noncoding region (NCR) that precludes ribosome scanning
(Fernandez-Munoz and Darnell, 1976; Fitzgerald and Semler, 2009;
Hewlett et al., 1976; Nomoto et al., 1976). Therefore, translation is
initiated in a cap-independent manner. The 5′ NCR is composed of six
stem-loop structures, where stem-loops II–VI make up the internal
ribosome entry site (IRES) that mediates cap-independent, IRES-driven
translation (Belsham and Sonenberg, 1996; Borman and Jackson, 1992;
Jang et al., 1988; Pelletier and Sonenberg, 1988). As a positive-sense
RNA virus, the genome can serve as a template for both viral
translation and RNA replication. Therefore, upon entry into the host
cell, the viral genome is ﬁrst used as a template for translation into a
single polyprotein that is subsequently processed by viral proteinases,
including 3CD, to produce viral proteins. Picornaviruses utilize host cell
proteins, referred to as IRES trans-acting factors (ITAFs), to mediate
non-canonical translation. Several host proteins have been shown to
be important for poliovirus or HRV translation, including poly(rC)
binding protein 2 (PCBP2), polypyrimidine tract binding protein (PTB),
lupus autoantigen (La), and upstream of N-ras (unr) (Blyn et al., 1996,
1997; Gamarnik and Andino, 1997; Gosert et al., 2000; Hellen et al.,
1993; Meerovitch et al., 1993; Sawicka et al., 2008; Svitkin et al., 1994).
Following translation, the genomic RNA can be used as a template
for synthesis of negative-strand RNA, followed by the subsequent
synthesis of positive-strand RNA for further rounds of translation and
RNA replication, or packaging into progeny virions. Previous studies
have shown that although the viral genome can be used as a template
for both translation and RNA replication, RNA that is actively being
translated cannot function as a template for RNA replication (Barton
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et al., 1999; Gamarnik and Andino, 1998). This suggests that there
must be a mechanism to mediate a switch in template usage from
translation to RNA replication.
Multiple candidates have been proposed to play a role in the
switch from viral translation to RNA synthesis, including PCBP2 and
PTB. PCBP2 binds to stem-loop IV of the poliovirus IRES to form a
complex that is required for translation of the polyprotein (Blyn et al.,
1996, 1997; Gamarnik and Andino, 1997). Additionally, PCBP2 binds to
a stem-loop I structure upstream of the IRES and forms a ternary
complex with viral proteinase 3CD that is required for initiation of
negative-strand RNA synthesis (Andino et al., 1993, 1990; Gamarnik
and Andino,1997, 1998; Parsley et al., 1997). At peak times of viral RNA
synthesis, PCBP2 is cleaved by poliovirus 3CD proteinase, disrupting
the interaction of PCBP2 with stem-loop IV and inhibiting translation.
However, the cleaved form of PCBP2 is still able to bind to stem-loop I
and form a functional ternary complex, remaining active in RNA
replication (Perera et al., 2007). Additional studies have shown that
PCBP2 is also cleaved during coxsackievirus infection and can be
cleaved in vitro by HRV type 16 (HRV16) 3CD proteinase (Chase et al.,
submitted for publication). Therefore, these data suggest that cleavage
of PCBP2 by viral 3CD proteinase could be important for mediating a
switch in template usage for multiple picornaviruses.
PTB is an additional ITAF that stimulates poliovirus and HRV
translation (Gosert et al., 2000; Hellen et al., 1993; Hunt et al.,
1999; Hunt and Jackson, 1999; Sawicka et al., 2008). It has been
shown that, like PCBP2, PTB is also cleaved during poliovirus or
HRV type 14 (HRV14) infection, and the cleavage is mediated by
the viral proteinase 3C (Back et al., 2002). PTB is a member of the
hnRNP family and shuttles from the nucleus to the cytoplasm
(Michael et al., 1995). Cleavage of PTB results in the redistribution
of the cleaved fragments to the cytoplasm and the inhibition of
poliovirus translation. While the mechanism of how PTB cleavage
inhibits translation is not known, it has been proposed that the
cleaved fragments bind viral RNA to preclude binding of full-
length, functional PTB (Back et al., 2002). Thus, it has been
proposed that cleavage of cellular protein PTB by viral proteinase
3C could also play a role in mediating a switch in template usage.
Cleavage of PCBP2 is required for efﬁcient poliovirus RNA replica-
tion, and plays an important role in mediating a switch in template
usage from translation to RNA replication (Chase et al., submitted for
publication). Since PCBP2 is cleaved by HRV16 viral proteinase 3CD,
this suggests that cleavage of PCBP2 could also be important for HRV
RNA replication and the switch in template usage. However, the role
host cell proteins play in HRV infection and the importance of PCBP2 or
PTB cleavage during HRV infection is not yet understood. To more fully
explore these mechanisms, PCBP2 cleavage was investigated dur-
ing infection with three different HRV serotypes, types 14, 16, and
1A, which includes serotypes from groups A or B and serotypes that
use either the major or minor group receptor. HRV14 and HRV16
utilize the major ICAM-1 receptor, while HRV1A uses the minor group
LDL receptor. In addition, HRV14 is grouped into group B, while HRV16
and HRV1A are group A serotypes. We found that PCBP2 and PTB are
cleaved during infection of HeLa cells by all three HRV serotypes inve-
stigated; however, neither protein was cleaved during infection of a
human lung ﬁbroblast cell line, suggesting differential cleavage of host
cell proteins. In addition, unlike poliovirus, cleavage of PTB or PCBP2
does not appear to be required for efﬁcient human rhinovirus infection.
Results
Cleavage of puriﬁed recombinant PCBP2 in vitro by poliovirus or HRV
3CD proteinases
Previous studies have shown that PCPB2 is cleaved by polio-
virus proteinase 3C or precursor 3CD (Perera et al., 2007). To
determine if PCBP2 is also cleaved by HRV 3CD proteinase,
recombinant poliovirus or HRV16 3CD proteinase was incubated
with puriﬁed PCBP2, and the electrophoretic mobilities of PCBP2
and cleavage products were analyzed by Western blot (Fig. 1).
PCBP2 and HRV16 or poliovirus 3CD proteinase recombinant
proteins were incubated for varying amounts of time, as indicated.
The level of cleaved PCBP2 increases during the ﬁrst 2 h and then
remains consistent during the remainder of the incubation period.
Comparing PCBP2 cleavage by poliovirus 3CD (lanes 2–5) to
cleavage by HRV16 3CD (lanes 6–9), the levels of cleaved PCBP2
are similar. We have also shown that HRV14 3CD can cleave PCBP2
with a similar efﬁciency (data not shown). These data suggest that
HRV 3CD can cleave PCBP2 as efﬁciently as poliovirus 3CD, further
suggesting that PCBP2 cleavage could be important during HRV
infection.
Cleavage of PCBP2 during HRV infection
Although HRV 3CD can cleave PCBP2 in vitro, the question
remains as to whether PCBP2 cleavage occurs during the course of
HRV infection. To address this question, HeLa cells were infected
with different serotypes of HRV, and cleavage of PCBP2 was
analyzed by Western blot, using antibodies speciﬁc for PCBP2.
HRV has slower growth kinetics than poliovirus, with peak titers
reached at 10 h post-infection compared to 4 h for poliovirus (data
not shown) (Lee and Wang, 2003). Therefore, extracts were
harvested out to 16 h post-infection to account for the protracted
time course. As expected, no cleavage of PCBP2 was detected in
mock-infected HeLa cells (Fig. 2A). In HRV14-infected HeLa cells,
PCBP2 cleavage was not detected until 14 h post-infection (Fig. 2B).
Additionally, cleaved PCBP2 could only be observed when four
times the total protein concentration was analyzed compared to
poliovirus. Human rhinovirus grows optimally in tissue culture at
34 1C, whereas poliovirus grows and replicates optimally at 37 1C,
although our work and the work of others has recently shown that
HRV16 and HRV14 can also replicate efﬁciently at 37 1C (data not
shown) (Papadopoulos et al., 1999). To determine if the lower
growth temperature contributes to the cleavage of PCBP2 seen
during HRV14 infection, poliovirus infection was carried out in
HeLa cells at 34 1C as a comparison. When HeLa cell lysates from
poliovirus-infected cells were analyzed by Western blot, PCBP2
cleavage was detected at 6 h post-infection (Fig. 2C). While this is
slightly delayed relative to cleavage of PCBP2 during poliovirus
infection at 37 1C, which is detected at 4 h post-infection, it still
occurs much earlier than what was observed during HRV14
infection (Chase et al., submitted for publication; Perera et al.,
2007). These results suggest that cleavage of PCBP2 during HRV14
infection is less efﬁcient than during poliovirus infection. To
determine if other rhinovirus serotypes cleave PCBP2 more
Fig. 1. Cleavage of recombinant PCBP2 by 3CD proteinase. Recombinant PCBP2 was
incubated with puriﬁed poliovirus or HRV16 3CD for 1 to 6 h, as indicated. PCBP2
alone is in lane 1. PCBP2 was incubated with recombinant poliovirus 3CD (lanes
2–5) or recombinant HRV16 3CD (lanes 6–9). The arrows to the right of the gel
image indicate full-length or cleaved PCBP2. Molecular weight markers are
indicated to the left of the gel image.
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efﬁciently than HRV14, HeLa cells were infected with a group A
HRV serotype, type 16 (HRV16), which is more similar in sequence
to circulating HRV serotypes than HRV14. Again, in mock-infected
cells, only full-length PCBP2 is detected (Fig. 3A). PCBP2 cleavage
during HRV16 infection was observed by 10–12 h post-infection,
delayed relative to cleavage during poliovirus infection, but not as
delayed as cleavage during HRV14 infection (Fig. 3B). Although
cleavage of PCBP2 is delayed until 10 h post-infection during
HRV16 infection, it corresponds to the delayed growth kinetics
compared to the poliovirus growth kinetics. These data conﬁrm
that PCBP2 can be cleaved during human rhinovirus infection of
HeLa cells.
PCBP2 remains intact during HRV infection of lung ﬁbroblast cells
To further determine the importance of PCBP2 cleavage during
rhinovirus infection, a human lung ﬁbroblast-derived WisL cell
line was utilized (Bochkov et al., 2011). As HRV infects the
respiratory tract, this cell line may allow for analysis of HRV
infection of cells more relevant than the standard HeLa cell model.
Cytoplasmic extracts from WisL cells infected with HRV16 were
collected and analyzed at indicated times post-infection. As seen
in Fig. 3C, cleavage products of PCBP2 cannot be detected out to
42 h (lane 10), and this was consistent when four times the total
protein concentration was analyzed (data not shown).
To ensure that a productive infection was occurring, cytoplas-
mic lysates from HRV16-infected HeLa cells or WisL cells were
analyzed by Western blot, using an antibody speciﬁc for HRV16 3D
RNA-dependent RNA polymerase. Viral proteins 3D and 3CD
precursor were detected at 8 h post-infection of WisL cells
(Fig. 4A). During HRV16 infection of HeLa cells, viral proteins were
detected at 6 h post-infection (Fig. 4B). The production of viral
proteins suggesting productive HRV infection of WisL cells was
further supported by single cycle growth analysis showing similar
growth during HRV16 infection of WisL cells compared to growth
kinetics during HRV16 infection of HeLa cells (Fig. 4C). Both the
growth analysis and production of viral proteins indicate that
HRV16 can productively infect WisL lung ﬁbroblast cells, although
PCBP2 is not cleaved. Therefore, we conclude that HRV16 can
productively infect WisL cells in the absence of PCBP2 cleavage.
To determine if PCBP2 can be cleaved in WisL cells, a poliovirus
infection of WisL cells was carried out. Following infection,
cytoplasmic lysate was harvested at indicated times post-infection,
and PCBP2 cleavage was analyzed by Western blot. In contrast to
HRV16 infection, cleavage of PCBP2 during poliovirus infection of
WisL cells is readily detected at 6 h post-infection, indicating that
PCBP2 can be cleaved during infection of WisL cells (Fig. 5A).
While the cleavage of PCBP2 during poliovirus infection of WisL
cells was slightly delayed relative to HeLa cells (detected at 4 h
post-infection), it corresponds to a slight delay in growth kinetics,
as indicated by the slightly delayed detection of viral proteins
(Fig. 5B). During infection of WisL cells, poliovirus 3CD proteinase
and 3D polymerase are detected at 4 and 6 h post-infection,
respectively, which is slightly delayed relative to detection during
infection of HeLa cells, when viral proteins are detected by 3 h
post-infection. These data demonstrate that poliovirus produc-
tively infects WisL cells, and that PCBP2 can be cleaved in WisL
cells during poliovirus infection. Therefore, the lack of cleavage
observed during HRV16 infection appears to be unique to HRV
infection.
To further characterize the cleavage state of PCBP2 during
HRV infection, WisL cells were infected with a group B serotype
Fig. 2. PCBP2 cleavage during HRV14 or poliovirus infection at 34 1C. To determine cleavage during infection at a lower temperature, HeLa cells were mock-infected (A) or
infected with HRV14 (B) or poliovirus (C). Cytoplasmic lysates from infected cells were collected at indicated times post-infection and were analyzed by Western blot with an
antibody speciﬁc to PCBP2. The arrows to the right of the gel image indicate full-length or cleaved PCBP2, and molecular weight markers are indicated to the left of the
gel image.
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(HRV14), which also utilizes the major group receptor, similar
to group A serotype HRV16, or with minor group HRV1A (Fig. 6).
During HRV14 infection of HeLa cells, cleaved PCBP2 is barely
detected at 12 h post-infection, but is readily detected by 24 h
post-infection (lanes 5 and 6). Similar to HRV16 infection, PCBP2 is
not cleaved during HRV14 infection of WisL cells (Fig. 6A, lanes
3 and 4). These data demonstrate that major group HRV serotypes
14 and 16 are able to cleave PCBP2 in HeLa cells, but this cleavage
event does not appear to be required for efﬁcient infection of WisL
cells. To determine if the observed lack of cleavage in WisL cells
was unique to major group rhinovirus types, WisL cells were
infected with minor group HRV1A. Similar to HRV14 and HRV16,
at 24 h post HRV1A infection of HeLa cells, cleaved PCBP2 is readily
detected (Fig. 6B, lane 7). Additional studies have shown that
PCBP2 cleavage during HRV1A infection of HeLa cells can also be
detected at 16 h post-infection, similar to both HRV14 and HRV16
(data not shown). However, during HRV1A infection of WisL cells,
cleaved PCBP2 is not detected (Fig. 6B, lanes 4 and 5), consistent
with what we observed for HRV16 or HRV14 infection of WisL
cells. Collectively, these data suggest that PCBP2 cleavage is not
necessary for efﬁcient HRV infection of WisL cells.
Cleavage of polypyrimidine tract binding protein during HRV infection
Previous studies have shown that cellular protein polypyrimi-
dine tract binding protein (PTB) enhances both poliovirus and HRV
IRES-mediated translation (Gosert et al., 2000; Hellen et al., 1993;
Hunt and Jackson, 1999; Sawicka et al., 2008). Additionally, PTB
can be cleaved during poliovirus infection by 3C/3CD proteinase,
and it has been proposed that the cleavage event can help mediate
a switch in template usage from translation to RNA replication
(Back et al., 2002). It has been reported that all three PTB isoforms
(PTB-1, -2, and -4) can be cleaved by 3CD, producing two major
cleavage products at 41 kDa and 39 kDa, and a minor cleavage
product at 16 kDa (Back et al., 2002). Therefore, this protein may
also be cleaved during HRV infection to help mediate initiation
of RNA replication by inhibiting translation to allow a switch in
template usage. To determine the cleavage state of PTB during HRV
infection, lysates from HRV16-infected HeLa cells were analyzed
by Western blot with an antibody speciﬁc for PTB. During infection
of HeLa cells at 34 1C, cleavage was detected by 12 h post-infection
(Fig. 7A, lane 7), and cleavage can also be detected as early as 10 h
post-infection (data not shown). Additionally, PTB cleavage was
detected by 12 h post-infection during HRV14 infection of HeLa
cells (Fig. 7A, lane 11). During HRV16 or HR14 infection, three
cleavage products were detected, two products with molecular
masses of approximately 27–30 kDa, and a product with a mole-
cular mass of approximately 13–14 kDa. To further determine if
PTB cleavage occurs during HRV infection, WisL lung ﬁbroblast
cells were infected with HRV16 or HRV14 and lysates were
collected at the indicated times post-infection and analyzed by
Western blot. Similar to what we observed for PCBP2, only trace
levels of PTB cleavage were detected in HRV16-infected WisL cells
(Fig. 7A, lanes 3 and 4). To conﬁrm the lack of cleavage, 2.5 times
the total protein concentration in lysates from WisL cells infected
with HRV16 was analyzed, and again only trace levels of PTB
cleavage were detected (Fig. 7A, lanes 5 and 6, indicated by the
asterisk). However, during HRV14 infection, PTB cleavage products
Fig. 3. Cleavage of PCBP2 during HRV16 infection of HeLa cells or WisL cells. Cytoplasmic lysates were harvested from infected cells and analyzed by Western blot with a
monoclonal antibody against PCBP2. HeLa cells were mock-infected (A) or infected with HRV16 (B), and cytoplasmic lysates were harvested from 0–16 h post-infection, as
indicated. (C) WisL cells derived from human fetal lung ﬁbroblast cells were mock-infected or infected with HRV16, and cytoplasmic extracts were collected out to 42 h post-
infection and analyzed for PCBP2 cleavage as described for (A) and (B). Arrows to the right of the gel image indicate full-length or cleaved PCBP2, and molecular weight
markers are indicated on the left of the gel image.
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were detected by 12 h post-infection; however, only low levels of
the largest PTB cleavage product PTB could be detected at 24 h post-
infection (Fig. 7A, compare lanes 9 and 10). This suggests that PTB
cleavage is not required for efﬁcient HRV16 infection, but PTB cleavage
may play a role in HRV14 infection. However, the cleavage of PTB
appears to be inefﬁcient in HRV14-infected cells, perhaps limiting the
possible role of this event in the HRV14 replication cycle.
To further analyze cleavage of PTB during HRV infection, cyto-
plasmic lysates from HeLa or WisL cells infected with minor receptor
group serotype HRV1A were analyzed, as shown in Fig. 7B. During
infection of HeLa cells, cleaved PTB was detected by 12 h post-
infection (lane 2), and at 24 h post-infection both higher and lower
molecular weight PTB cleavage products were detected (lane 3).
However, during infection of WisL cells by HRV1A, only a trace
amount of PTB cleavage product is detected at 12 or 24 h post-
infection (lanes 5 and 6). From these data, it can be concluded that
while PTB cleavage occurs during HRV infection of HeLa cells, it is not
detected during HRV infection of WisL cells and does not appear to
be necessary for HRV replication in these cells.
Fig. 4. Detection of HRV16 proteins during infection of HeLa or WisL cells.
To ensure that a progressive infection was occurring, we analyzed cytoplasmic
lysates from infected WisL lung ﬁbroblast cells (A) or HeLa cells (B) by Western blot
with an antibody speciﬁc for HRV16 3D polymerase. Lane 1 [and lane 2 in (B)] is
extract from mock-infected cells as a control. The arrows to the right of the gel
image indicate 3CD, 3D, or 3D′ viral protein products. Molecular weight markers
are indicated on the left of the gel image. (C) Single cycle growth analysis of HeLa
cells (blue) or WisL cells (green) infected with HRV16 was analyzed by determining
plaque-forming units per ml (pfu/ml).
Fig. 5. Poliovirus infection of WisL cells. Human lung ﬁbroblast WisL cells were
infected with poliovirus and cytoplasmic lysates were collected from 0–12 h post-
infection, as indicated at the top of the gel image, and analyzed by Western blot.
(A) Western blot analysis with an antibody speciﬁc for PCBP2, with the cleaved or
full-length forms of the protein indicated to the right of the gel image. (B) Western
blot analysis with poliovirus 3CD speciﬁc antibodies to verify a productive viral
infection. 3CD precursor protein and 3D or 3D′ products are indicated to the right
of the gel image. Lane 6 displays extract from mock-infected cells as a control.
Molecular weight markers are indicated to the left of the gel image.
Fig. 6. PCBP2 cleavage during human rhinovirus infection. HeLa or WisL cells were
infected with HRV and cytoplasmic lysates were collected at indicated times post-
infection. The collected lysates were then analyzed by Western blot with an antibody
speciﬁc for PCBP2. (A) Cells were infected with HRV14. Extracts from mock-infected
WisL or HeLa cells are shown in lanes 1 and 2, respectively. Lysates from infected HeLa
cells are shown in lanes 3 and 4, and lysates from infected WisL cells are analyzed in
lanes 5 and 6. (B) WisL (lanes 3-5) or HeLa cells (lanes 6 and 7) were infected with
HRV1A. Extracts from mock-infected WisL or HeLa cells are analyzed in lanes 1 or 2,
respectively. Arrows on the right of the gel image indicate full-length or cleaved PCBP2,
and molecular weight markers are on the left of the gel image.
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Differential cleavage of host proteins during coxsackievirus infection
of different cell types
Coxsackievirus, also a member of the picornavirus family of
viruses, has similar growth properties to poliovirus. Coxsackievirus
grows and replicates optimally at 37 1C and has similar replication
kinetics, with peak titer being reached at 5 h post-infection. PCBP2
is cleaved during coxsackievirus infection at a similar time post-
infection to PCBP2 cleavage during poliovirus infection (Chase
et al., submitted for publication). To determine if coxsackievirus
cleaves PCBP2 differentially in HeLa versus WisL cells, both cell
lines were infected with coxsackievirus and the resulting cyto-
plasmic lysates from infected cells were analyzed by Western blot.
During coxsackievirus infection of HeLa cells, PCBP2 is cleaved
beginning at 4–6 h post-infection (Fig. 8A), further demonstrating
that PCBP2 cleavage during coxsackievirus infection is similar
relative to cleavage during poliovirus infection. However, during
coxsackievirus infection of WisL human lung ﬁbroblast cells, only a
small amount of cleaved PCBP2 is detected at 12 h post-infection
(Fig. 8B). This is delayed relative to observed PCBP2 cleavage at 6 h
following poliovirus infection of WisL cells, indicating that cox-
sackievirus may cleave PCBP2 differentially based on cell type.
To further characterize differential cleavage of host proteins
during coxsackievirus infection, PTB cleavage was analyzed in
WisL or HeLa cells infected with coxsackievirus. Cytoplasmic
lysates from HeLa- or WisL-infected cells were analyzed by
Western blot for PTB cleavage. As shown in Fig. 8C, the higher
molecular weight PTB cleavage products are detected at 4 h post-
infection in HeLa cells, and the lower molecular weight product is
seen by 8 h post-infection. During coxsackievirus infection of WisL
cells, only one of the major PTB cleavage products is detected at
6 h post-infection, and is more readily detected at 8 h post-
infection (Fig. 8D). Similar to PCBP2 cleavage, a very low level
of cleaved product is observed relative to infection of HeLa
cells, further suggesting that there is a signiﬁcant difference in
cleavage of host cell proteins PTB and PCBP2 during coxsackievirus
Fig. 7. PTB cleavage during human rhinovirus infection. HeLa or WisL cells were infected with HRV14, 16, or 1A, as described for Fig. 6. Lysates were analyzed byWestern blot
utilizing an antibody speciﬁc for PTB. (A) Cells were infected with HRV16 or HRV14. Lanes 1 and 2 display extracts from mock-infected WisL or HeLa cells, respectively.
Extracts from HRV16-infected WisL cells are shown in lanes 3–6, with 100 μg total protein in lanes 3 and 4, and 250 μg total protein in lanes 5 and 6 (indicated by the
asterisks). Lanes 7 and 8 show lysates from HRV16-infected HeLa cells, with 100 μg total protein analyzed. Lanes 9–12 analyze WisL cells (lanes 9 and 10) or HeLa cells (lanes
11 and 12) infected with HRV14. Arrows to the right of the gel image indicate full-length or cleaved PTB. (B) Cells were infected with HRV1A, and cytoplasmic lysates were
collected at 12 or 24 h post-infection. Mock-infected HeLa cell or WisL cell lysates (lanes 1 and 4, respectively) conﬁrm full-length PTB. Lysates from HRV1A-infected HeLa
cells are in lanes 2 and 3, and lysates from HRV1A-infected WisL cells are analyzed in lanes 5 and 6. Full-length and cleaved forms of PTB are indicated by the arrows to the
right of the gel image and molecular weight markers are indicated to the left of the gel image.
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infection, based on cell type being infected. Taken together, these
data suggest that, unlike poliovirus infection, cleavage of host cell
proteins PCBP2 or PTB is not required for efﬁcient HRV or
coxsackievirus infection.
Discussion
Human rhinovirus translation is driven in a cap-independent,
IRES-dependent manner. Several host cell proteins help mediate
this non-canonical translation, known as IRES trans-acting factors
(ITAFs), including PCBP2 and PTB (Blyn et al., 1996, 1997;
Gamarnik and Andino, 1997; Gosert et al., 2000; Hellen et al.,
1993; Hunt and Jackson, 1999; Sawicka et al., 2008). PCBP2 is
cleaved during poliovirus infection by the 3CD proteinase, and it
has been proposed that the cleavage event helps mediate a switch
in template usage by inhibiting translation (Perera et al., 2007).
Additionally, PTB is known to stimulate both poliovirus and HRV
translation. Cleavage of PTB by poliovirus 3C proteinase also leads
to an inhibition in translation, and thus has also been proposed to
be involved in mediating a switch in template usage (Back et al.,
2002; Hunt and Jackson, 1999). The picornavirus genome can be
used as a template for both translation and RNA replication, and it
has been shown that a template actively being translated cannot
function as a template for RNA replication (Barton et al., 1999;
Gamarnik and Andino, 1998). A switch in template usage is
essential for efﬁcient viral RNA synthesis, and could therefore be
important for the progression of the replication cycle.
HRV serotypes can be divided into group A, group B, or group C,
and also by the receptor used to mediate cell entry; major group
serotypes use ICAM-I and minor group serotypes utilize low-
density lipoprotein (LDL) receptor. To provide a more comprehen-
sive study of the cleavage or use of host cell proteins PCBP2 and
PTB during human rhinovirus infection, serotypes representing
different groups were studied. HRV16, group A, and HRV14, group
B, are both major group serotypes, and HRV1A, group A, is a minor
group serotype. PCBP2 and PTB were both shown to be cleaved
during the course of HRV14, HRV16, or HRV1A infection of HeLa
cells, suggesting that PCBP2 might also be important for a switch
in template usage during HRV infection of HeLa cells. During
HRV16 or HRV14 infection of HeLa cells, PCBP2 cleavage is
detected at 10 or 14 h post-infection, respectively, while cleavage
is also detected prior to 24 h during HRV1A infection (Figs. 2, 3,
and 6; summarized in Table 1). In contrast, HRV infected WisL
human lung ﬁbroblast cells showed a lack of PCBP2 cleavage out to
24 h post-infection during HRV16, HRV14, or HRV1A infection
(Figs. 3 and 6; Table 1). However, single cycle growth analysis
and Western blot analysis with an antibody speciﬁc for HRV16 3D
polymerase indicated that there was a productive HRV16 infection
occurring in WisL cells (Fig. 4). Additionally, although slightly
delayed, PCBP2 cleavage was observed in WisL cells during
poliovirus infection. The observed delay is consistent with the
delay in viral protein accumulation, suggesting that poliovirus
infection may be slightly delayed in WisL cells, but that cleavage of
PCBP2 is still necessary for infection (Fig. 5). This demonstrates
that PCBP2 can be cleaved in WisL cells, and that the lack of
observed cleavage in this cell line appears to be unique to HRV
infection.
As it is known that other cellular proteins such as PTB can be
cleaved by 3C proteinase, and the cleavage could also help mediate
a switch in template usage, further analysis was carried out on
cleavage of PTB during HRV infection of WisL cells. The data
showed that PTB was cleaved during HRV14, HRV16, or HRV1A
infection of HeLa cells, but similar to PCBP2, PTB was also not
cleaved efﬁciently during HRV infection of WisL cells (Fig. 7,
Table 1). Because HRV can establish a productive infection of WisL
cells, our data suggest that cleavage of PCBP2 or PTB is not
necessary for efﬁcient HRV infection of these cells.
Coxsackievirus has similar growth kinetics to poliovirus, and it
has been shown that PCBP2 is cleaved during coxsackievirus
infection of HeLa cells with similar kinetics to cleavage during
poliovirus infection (Chase et al., submitted for publication).
Fig. 8. Cleavage of PCBP2 and PTB during coxsackievirus infection. HeLa or WisL
cells were infected with coxsackievirus B3 (CVB3), and cytoplasmic lysates were
analyzed by Western blot with antibodies speciﬁc for host cell proteins PCBP2 or
PTB. (A) HeLa cells or (B) WisL cells were infected with CVB3 and PCBP2 cleavage
was analyzed. Lysates from mock-infected cells were analyzed in lane 1. Arrows to
the right of the gel image indicate full-length or cleaved PCBP2. To determine the
status of PTB cleavage, cytoplasmic lysates from CVB3-infected HeLa cells (C) or
WisL cells (D) were analyzed by Western blot with an antibody speciﬁc for PTB.
Lysate from mock-infected cells is shown in lane 1. Arrows to the right of the gel
image indicate full-length or cleaved PTB. The molecular weight standards are
shown on the left of the gel image.
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Therefore, we hypothesized that PCBP2 cleavage would also occur
during coxsackievirus infection of WisL cells, similar to what was
observed during poliovirus infection of WisL cells (Fig. 5). How-
ever, PCBP2 cleavage was signiﬁcantly delayed and less efﬁcient
during coxsackievirus infection of WisL cells compared to infection
of HeLa cells. When cleavage of PTB was analyzed, there was a
similar occurrence in which PTB cleavage was both less efﬁcient
and delayed. Taken together, these data suggest that efﬁcient
coxsackievirus infection of WisL cells does not require PCBP2 or
PTB cleavage.
Our results lead to several questions, including why PCBP2 and
PTB are cleaved during infection of HeLa cells but not in WisL cells,
and if there are other, as yet undeﬁned, ITAFs that are important
for HRV and/or coxsackievirus translation in WisL cells that may
be less abundant in HeLa cells. Additional studies are necessary to
better understand the intracellular determinants required for HRV
translation and RNA replication, and work will need to be done
in multiple cell lines including, but not limited to, HeLa cells and
WisL cells. Since PCBP2 and PTB are cleaved during poliovirus
infection of WisL cells, the reason PCBP2 and PTB are differentially
cleaved during HRV infection of WisL cells but not during
poliovirus infection is not understood. Perhaps there is a lower
concentration of PCBP2 present in replication complexes formed
during infection of WisL cells, leading to the decreased detection
of cleaved PCBP2. During HRV infection of HeLa cells, PCBP2
cleavage is delayed relative to cleavage during poliovirus infection,
suggesting that PCBP2 cleavage may be less efﬁcient during HRV
infection, and the lower local concentration of PCBP2 would result
in a lack of detectable levels of PCBP2 cleavage. Alternatively,
PCBP2 or PTB may be bound to cellular RNA or host cell proteins,
making them unavailable as cleavage substrates during HRV
infection of WisL cells.
It has been proposed that cleavage of both PCBP2 and PTB helps
to mediate a switch in poliovirus template usage from translation
to RNA replication to allow the progression of RNA synthesis (Back
et al., 2002; Perera et al., 2007). Therefore, the question remains as
to what mediates the switch in HRV template usage. The cellular
protein upstream of N-ras (unr) has been shown to be important
for HRV translation, and can stimulate HRV translation alone and
synergistically with PTB (Hunt et al., 1999). Thus, unr could be an
important protein involved in template switching (Hunt et al.,
1999; Hunt and Jackson, 1999). However, preliminary data sug-
gests that unr is not cleaved in either HeLa cells or WisL cells
during HRV16 infection (data not shown).
Previous studies have shown that when 3CD is bound to stem-
loop I, levels of translation are decreased while levels of RNA
replication increase, and, correspondingly, in the absence of bound
3CD, translation is increased (Gamarnik and Andino, 1998).
Subsequent work indicated that in the presence of 3CD, PCBP2
preferentially binds to stem-loop I. The apparent dissociation
constant of PCBP2 for poliovirus stem-loop IV is approximately
15 nM, while that of PCBP2 to stem-loop I, in the absence of 3CD,
is approximately 95 nM. In the presence of 3CD, the dissociation
constant of PCBP2 for stem-loop IV is unaltered, but that of PCBP2
for stem-loop I changes to approximately 1 nM (Gamarnik and
Andino, 2000). Additionally, competition assays indicated that
PCBP2 bound to poliovirus stem-loop IV can be reduced in the
presence of 3CD bound to stem-loop I (Gamarnik and Andino,
2000). As originally proposed by Gamarnik and Andino (1998) for
poliovirus, the shift in the binding afﬁnity of PCBP2 for stem-loop I
over stem-loop IV in the presence of 3CD could help mediate a
switch in template usage from translation to RNA replication
independent of the cleavage state of PCBP2 or PTB. As translation
of the genomic template proceeds, the concentration of viral
proteins, including 3CD, would increase. 3CD interacts with
stem-loop I, shifting the occupancy of PCBP2 from stem-loop IV
to stem-loop I, and in the process inhibits translation while
allowing the initiation of negative-strand RNA synthesis. The
change in PCBP2 binding afﬁnity from stem-loop I to stem-loop
IV in the presence of 3CD proteinase could be the fundamental
mechanism mediating template switching, and could be augmen-
ted by cleavage of host cell proteins such as PCBP2 and PTB by viral
proteinase 3CD. Since it has been shown that PCBP2 cleavage is
important for poliovirus infection, the cleavage of PCBP2 would
mediate a more efﬁcient or a faster switch in template usage.
As coxsackievirus infection has similar growth properties as
poliovirus infection, this would suggest that an alternative
mechanism, that is as yet unknown, helps improve the switch in
template usage. HRV growth and replication are delayed relative to
poliovirus, which could be attributed to a less efﬁcient switch in
template usage, leading to a delay in RNA synthesis. During
poliovirus infection, the template switch could occur more quickly
as cellular protein PCBP2 is cleaved by 3CD to inhibit the RNP
complex formed between PCBP2 and stem-loop IV, potentiating
the change in PCBP2 binding from stem-loop IV to stem-loop I.
Further studies are necessary to identify the mechanism(s) that
mediate a switch in HRV template usage.
Materials and methods
HRV16 3CD construct
Synthetic oligonucleotide primers used were: HRV16-3CD-Nde
(þ) (5′ agccatatgggtccagaagaagaattt 3′),
HRV16-3CD-BamHI() (5′ gccggatccctattaagaatttttcatacatt 3′),
HRV16-3CDμ10(þ) (5′ atcatacttcactgaacaagcagcccaaattcaaatct-
ctaaac 3′),
HRV16-3CDμ10() (5′ gtttagagatttgaatttgggctgcttgttcagtgaag-
tatgat 3′). Synthetic oligonucleotide primers HRV16-3CD-Nde (þ)
Table 1
Summary of when cleavage of host cell proteins PCBP2 and PTB is detected during picornavirus infections.
Virus Cell type PCBP2 PTB
HRV16—34 1C HeLa 10 hpi 10 hpi
HRV16—37 1C HeLa 4 hpi 8 hpi
HRV16—34 1C WisL Not detected up to 42 hpi Not detected at 32 hpi
HRV14—34 1C HeLa 14 hpi (with 4 total protein) 10 hpi; signiﬁcantly more detected 12 hpi
HRV14—34 1C WisL Not detected up to 32 hpi Not detected up to 32 hpi
HRV1A—34 1C HeLa 16 hpi 12 hpi
HRV1A—34 1C WisL Not detected out to 24 hpi Not detected out to 24 hpi
Coxsackievirus—37 1C HeLa 4 hpi 4 hpi
Coxsackievirus—37 1C WisL 12 hpi and at signiﬁcantly levels 6–8 hpi, and signiﬁcantly lower lower levels
Poliovirus—37 1C HeLa 4 hpi 3 hpia
Poliovirus—37 1C WisL 6 hpi 4 hpi
a Back et al. (2002).
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and HRV16-3CD-BamHI() were used to generate PCR fragments
containing HRV16 amino acids 5155 to 7085, ﬂanked by NdeI or
BamHI upstream or downstream, respectively. The restriction sites
were then used to clone HRV16 3CD into the pET15b vector
through ligation. Site-directed mutagenesis of the newly synthe-
sized pET15b HRV16 3CD plasmid was then used as a template for
site-directed mutagenesis to alter the 3C/D self-cleavage site such
that recombinant 3CD could not be self-cleaved into 3C and 3D.
The synthetic oligonucleotide primers used were HRV16-3CDμ10
(þ) and the reverse complement, HRV16-3CDμ10(). The result-
ing plasmid, pET15b HRV16 3CDμ10, was used for protein
expression.
Protein puriﬁcation
Puriﬁcation of hexahistidine-tagged pET22b PCBP2 was carried out
as previously described (Parsley et al., 1997; Perera et al., 2007). Brieﬂy,
PCBP2 was expressed in BL21DE3 (Rosetta) cells. The cells were grown
at 37 1C to an A600 of 0.6 and then induced with isopropyl-β-D-
thiogalactopyranoside (IPTG; 1 mM concentration) for 3 h at 25 1C.
Cells were resuspended in lysozyme buffer without lysozyme (10 mM
EDTA, 25 mM Tris–HCl [pH 8.0], 4.5% glucose) and lysed by sonication,
15 s followed by 1min on ice repeated ﬁve times. The soluble fraction
following sonicationwas precipitated with ammonium sulfate (20% w/
v). The resulting pellet fraction was dialyzed overnight in I-60 buffer
(20 mM Tris–HCl [pH 8.0], 250 mM NaCl, 60 mM imidazole, 10%
glycerol) with 0.5% NP-40. The fraction was then subjected to Ni2þ
ion-based afﬁnity chromatography (GE Healthcare). The column was
washed with I-60 buffer, and the protein was eluted with I-200 buffer
(20 mM Tris–HCl [pH 8.0], 250 mM NaCl, 200 mM imidazole, 10%
glycerol).
Hexahistidine-tagged 3CD viral proteinase (poliovirus or
HRV16) was puriﬁed as previously described, with minor mod-
iﬁcations (Parsley et al., 1999, 1997). Brieﬂy, 3CD was expressed in
BL21DE3 (Rosetta) cells, and the cells were grown at 37 1C to an
A600 of 0.4. The protein expression was induced by the addition of
IPTG (1 mM) for 3 h at 25 1C. Cells were resuspended in Buffer A
(20 mM Tris–HCl [pH 8.0], 25 mM NaCl, 5% glycerol, 1 mM DTT,
added fresh) and lysed by one passage through a French pressure
cell (Amicon) at 8,000 psi. The lysate was then subjected to
centrifugation for 20 min at 13,800g using a Beckman Coulter
centrifuge and JA-17 rotor and the resulting supernatant was
discarded. The pellet was washed three times in Buffer A, the last
wash without DTT. To extract protein from the pellet fraction, the
pellet was resuspended in high salt I-30 buffer (20 mM Tris–HCl
[pH 8.0], 1 M NaCl, 30 mM imidazole, 10% glycerol) and incubated
on ice for 30 min. The resuspended pellet was then subjected
to centrifugation for 20 min at 13,800g as above. The resulting
supernatant was subjected to Ni2þ ion-based afﬁnity chromato-
graphy (GE Healthcare). The column was washed with high salt
I-30 buffer, and the protein was eluted with high salt I-200 buffer
(20 mM Tris–HCl [pH 8.0], 1 M NaCl, 200 mM imidazole, 10%
glycerol).
In vitro cleavage assay
The in vitro cleavage assay was carried out as previously
described, with some minor changes (Perera et al., 2007). Brieﬂy,
recombinant puriﬁed PCBP2 and poliovirus or HRV16 3CD protei-
nase were incubated at a 1:1 M ratio in cleavage buffer (20 mM
HEPES [pH 7.4], 1 mM DTT, 150 mM KOAc) for 1 to 6 h at 30 1C. The
cleavage products were analyzed by SDS-PAGE and Western blot.
Western blot analysis
Following SDS-PAGE, proteins were electroblotted to a PVDF
membrane. The membranes were blocked in 5% milk in phosphate
buffered saline (PBS) with 0.1% Tween-20 for 1 h at room tem-
perature. Mouse monoclonal antibody against PCBP2 (1:2000 in
PBS with 0.1% Tween-20), as described in Sean et al., was used to
detect full-length and cleaved forms of PCBP2 (Sean et al., 2008).
To detect PTB protein, mouse monoclonal antibody against PTB
(1:2000 in PBS with 0.1% Tween-20) was used. Poliovirus viral
proteins were analyzed with a rabbit polyclonal antibody against
poliovirus 3CD proteinase (Cathcart et al., 2013). HRV16 viral
proteins were detected with a rabbit polyclonal antibody against
HRV16 3D RNA-dependent RNA polymerase. A synthetic HRV16 3D
peptide was generated and used to induce antibody production in
rabbits (Bethyl). The PVDF membrane was incubated with anti-
PCBP2, anti-PTB, anti-poliovirus 3CD, or anti-HRV16 3D antibody
(1:2000) for 1 h. This was followed by incubation with goat
anti-mouse horseradish peroxidase (HRP) secondary antibody
(Millipore) or goat anti-rabbit HRP antibody (Millipore) for 1 h.
Protein bands were visualized using chemiluminescence (Thermo
Scientiﬁc).
Virus infection and cell culture
HeLa cells were grown as monolayers in Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 8% newborn calf serum
(NCS). WisL human fetal lung ﬁbroblast cells (Bochkov et al., 2011)
were grown as monolayers in DMEM supplemented with 10% fetal
bovine serum (FBS). Cells (HeLa or WisL) were infected with polio-
virus, coxsackievirus B3 (CVB3), HRV14, HRV16, or HRV1A at a multi-
plicity of infection (MOI) of 20, and adsorptionwas carried out at room
temperature for 60 min for HRV or 30 min for poliovirus and
coxsackievirus. HRV1A virus stock was kindly provided by Dr. Yury
Bochkov (University of Wisconsin–Madison). DMEM with 8% NCS
(HeLa cells) or 10% FBS (WisL cells) was added, and the cells were
incubated at 34 1C or 37 1C, as speciﬁed, until the indicated times. At
speciﬁc times post-infection, cells were washed twice with phosphate
buffered saline (PBS), scraped, and collected to generate cytoplasmic
lysates. Cells were lysed in NP-40 lysis buffer (50 mM Tris–HCl [pH
8.0], 5 nM EDTA [pH 8.0], 150 mMNaCl, 0.5% NP-40) on ice for 30 min.
After incubation on ice, cells debris was pelleted, the resulting super-
natant was collected, and total protein concentration was determined
by Bradford assay. Total protein (100 μg) from cytoplasmic lysates
were analyzed by Western blot. Where indicated, four times total
protein concentration (400 ug) or 2.5 times total protein concentration
(250 ug) was analyzed.
For single cycle growth analysis, HeLa cells or WisL cells were
infected with HRV16 at an MOI of 20 as above. Cells were washed
three times with phosphate buffered saline (PBS) following the
adsorption prior to adding media. At designated times post-
infection (0–12 h), supernatant and cells were collected and
subjected to four rounds of freeze–thawing. To determine the titer
of virus at each time point, the collected virus was then diluted in
serum-free media and the dilutions were used to infect HeLa cell
monolayers (as above). Following adsorption, the cells were over-
laid with DMEM plus 8% NCS and 0.45% agarose. Seven days after
infection, the cells were treated with 10% trichloroacetic acid (TCA)
and stained with crystal violet (0.1% crystal violet, 25% ethanol).
The plaques were counted to determine the virus titer.
Acknowledgments
We are grateful to Andrea Cathcart and Sonia Maciejewski for
critical comments on the manuscript. We thank Dr. Yury Bochkov
A.J. Chase, B.L. Semler / Virology 449 (2014) 35–44 43
for generously providing the HRV1A virus stock and the WisL cell
line. We thank Hung Nguyen and MyPhuong Tran for their expert
technical assistance. The research was supported by Public Health
Service grant AI026765 from the National Institutes of Health.
References
Andino, R., Rieckhof, G.E., Achacoso, P.L., Baltimore, D., 1993. Poliovirus RNA
synthesis utilizes an RNP complex formed around the 5′-end of viral RNA.
EMBO J. 12, 3587–3598.
Andino, R., Rieckhof, G.E., Baltimore, D., 1990. A functional ribonucleoprotein
complex forms around the 5′ end of poliovirus RNA. Cell 63, 369–380.
Arruda, E., Pitkaranta, A., Witek Jr., T.J., Doyle, C.A., Hayden, F.G., 1997. Frequency
and natural history of rhinovirus infections in adults during autumn. J. Clin.
Microbiol. 35, 2864–2868.
Back, S.H., Kim, Y.K., Kim, W.J., Cho, S., Oh, H.R., Kim, J.E., Jang, S.K., 2002. Translation
of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding
proteins executed by polioviral 3C(pro). J. Virol. 76, 2529–2542.
Barton, D.J., Morasco, B.J., Flanegan, J.B., 1999. Translating ribosomes inhibit
poliovirus negative-strand RNA synthesis. J. Virol. 73, 10104–10112.
Belsham, G.J., Sonenberg, N., 1996. RNA-protein interactions in regulation of
picornavirus RNA translation. Microbiol. Rev. 60, 499–511.
Blyn, L.B., Swiderek, K.M., Richards, O., Stahl, D.C., Semler, B.L., Ehrenfeld, E., 1996.
Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5′
noncoding region: identiﬁcation by automated liquid chromatography-tandem
mass spectrometry. Proc. Natl. Acad. Sci. USA 93, 11115–11120.
Blyn, L.B., Towner, J.S., Semler, B.L., Ehrenfeld, E., 1997. Requirement of poly(rC)
binding protein 2 for translation of poliovirus RNA. J. Virol. 71, 6243–6246.
Bochkov, Y.A., Palmenberg, A.C., Lee, W.M., Rathe, J.A., Amineva, S.P., Sun, X., Pasic, T.
R., Jarjour, N.N., Liggett, S.B., Gern, J.E., 2011. Molecular modeling, organ culture
and reverse genetics for a newly identiﬁed human rhinovirus C. Nat. Med. 17,
627–632.
Borman, A., Jackson, R.J., 1992. Initiation of translation of human rhinovirus RNA:
mapping the internal ribosome entry site. Virology 188, 685–696.
Cathcart, A.L., Rozovics, J.M., Semler, B.L., 2013. Cellular mRNA decay protein AUF1
negatively regulates enterovirus and human rhinovirus infections. J. Virol..
Fernandez-Munoz, R., Darnell, J.E., 1976. Structural difference between the 5′
termini of viral and cellular mRNA in poliovirus-infected cells: possible basis
for the inhibition of host protein synthesis. J. Virol. 18, 719–726.
Fitzgerald, K.D., Semler, B.L., 2009. Bridging IRES elements in mRNAs to the
eukaryotic translation apparatus. Biochim. Biophys. Acta 1789, 518–528.
Gamarnik, A.V., Andino, R., 1997. Two functional complexes formed by KH domain
containing proteins with the 5′ noncoding region of poliovirus RNA. RNA 3,
882–892.
Gamarnik, A.V., Andino, R., 1998. Switch from translation to RNA replication in a
positive-stranded RNA virus. Genes Dev. 12, 2293–2304.
Gamarnik, A.V., Andino, R., 2000. Interactions of viral protein 3CD and poly(rC)
binding protein with the 5′ untranslated region of the poliovirus genome.
J. Virol. 74, 2219–2226.
Gosert, R., Chang, K.H., Rijnbrand, R., Yi, M., Sangar, D.V., Lemon, S.M., 2000.
Transient expression of cellular polypyrimidine-tract binding protein stimu-
lates cap-independent translation directed by both picornaviral and ﬂaviviral
internal ribosome entry sites in vivo. Mol. Cell. Biol. 20, 1583–1595.
Hellen, C.U., Witherell, G.W., Schmid, M., Shin, S.H., Pestova, T.V., Gil, A., Wimmer,
E., 1993. A cytoplasmic 57-kDa protein that is required for translation of
picornavirus RNA by internal ribosomal entry is identical to the nuclear
pyrimidine tract-binding protein. Proc. Natl. Acad. Sci. USA 90, 7642–7646.
Hewlett, M.J., Rose, J.K., Baltimore, D., 1976. 5′-terminal structure of poliovirus
polyribosomal RNA is pUp. Proc. Natl. Acad. Sci. USA 73, 327–330.
Hunt, S.L., Hsuan, J.J., Totty, N., Jackson, R.J., 1999. unr, a cellular cytoplasmic RNA-
binding protein with ﬁve cold-shock domains, is required for internal initiation
of translation of human rhinovirus RNA. Genes Dev. 13, 437–448.
Hunt, S.L., Jackson, R.J., 1999. Polypyrimidine-tract binding protein (PTB) is
necessary, but not sufﬁcient, for efﬁcient internal initiation of translation of
human rhinovirus-2 RNA. RNA 5, 344–359.
Jang, S.K., Krausslich, H.G., Nicklin, M.J., Duke, G.M., Palmenberg, A.C., Wimmer, E.,
1988. A segment of the 5′ nontranslated region of encephalomyocarditis virus
RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62,
2636–2643.
Johnston, S.L., Pattemore, P.K., Sanderson, G., Smith, S., Campbell, M.J., Josephs, L.K.,
Cunningham, A., Robinson, B.S., Myint, S.H., Ward, M.E., Tyrrell, D.A., Holgate, S.T.,
1996. The relationship between upper respiratory infections and hospital
admissions for asthma: a time-trend analysis. Am. J. Respir. Crit. Care Med.
154, 654–660.
Lee, W.M., Wang, W., 2003. Human rhinovirus type 16: mutant V1210A requires
capsid-binding drug for assembly of pentamers to form virions during mor-
phogenesis. J. Virol. 77, 6235–6244.
McErlean, P., Shackelton, L.A., Andrews, E., Webster, D.R., Lambert, S.B., Nissen, M.D.,
Sloots, T.P., Mackay, I.M., 2008. Distinguishing molecular features and clinical
characteristics of a putative new rhinovirus species, human rhinovirus C (HRV C).
PLoS One 3, e1847.
Meerovitch, K., Svitkin, Y.V., Lee, H.S., Lejbkowicz, F., Kenan, D.J., Chan, E.K., Agol, V.
I., Keene, J.D., Sonenberg, N., 1993. La autoantigen enhances and corrects
aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 67,
3798–3807.
Michael, W.M., Choi, M., Dreyfuss, G., 1995. A nuclear export signal in hnRNP A1: a
signal-mediated, temperature-dependent nuclear protein export pathway. Cell
83, 415–422.
Nomoto, A., Lee, Y.F., Wimmer, E., 1976. The 5′ end of poliovirus mRNA is not
capped with m7G(5′)ppp(5′)Np. Proc. Natl. Acad. Sci. USA 73, 375–380.
Papadopoulos, N.G., Sanderson, G., Hunter, J., Johnston, S.L., 1999. Rhinoviruses
replicate effectively at lower airway temperatures. J. Med. Virol. 58, 100–104.
Parsley, T.B., Cornell, C.T., Semler, B.L., 1999. Modulation of the RNA binding and
protein processing activities of poliovirus polypeptide 3CD by the viral RNA
polymerase domain. J. Biol. Chem. 274, 12867–12876.
Parsley, T.B., Towner, J.S., Blyn, L.B., Ehrenfeld, E., Semler, B.L., 1997. Poly (rC)
binding protein 2 forms a ternary complex with the 5′-terminal sequences of
poliovirus RNA and the viral 3CD proteinase. RNA 3, 1124–1134.
Pelletier, J., Sonenberg, N., 1988. Internal initiation of translation of eukaryotic
mRNA directed by a sequence derived from poliovirus RNA. Nature 334,
320–325.
Perera, R., Daijogo, S., Walter, B.L., Nguyen, J.H., Semler, B.L., 2007. Cellular protein
modiﬁcation by poliovirus: the two faces of poly(rC)-binding protein. J. Virol.
81, 8919–8932.
Rakes, G.P., Arruda, E., Ingram, J.M., Hoover, G.E., Zambrano, J.C., Hayden, F.G.,
Platts-Mills, T.A., Heymann, P.W., 1999. Rhinovirus and respiratory syncytial
virus in wheezing children requiring emergency care. IgE and eosinophil
analyses. Am. J. Respir. Crit. Care Med. 159, 785–790.
Sawicka, K., Bushell, M., Spriggs, K.A., Willis, A.E., 2008. Polypyrimidine-tract-
binding protein: a multifunctional RNA-binding protein. Biochem. Soc. Trans.
36, 641–647.
Sean, P., Nguyen, J.H., Semler, B.L., 2008. The linker domain of poly(rC) binding
protein 2 is a major determinant in poliovirus cap-independent translation.
Virology 378, 243–253.
Svitkin, Y.V., Meerovitch, K., Lee, H.S., Dholakia, J.N., Kenan, D.J., Agol, V.I.,
Sonenberg, N., 1994. Internal translation initiation on poliovirus RNA: further
characterization of La function in poliovirus translation in vitro. J. Virol. 68,
1544–1550.
A.J. Chase, B.L. Semler / Virology 449 (2014) 35–4444
